Search by Drug Name or NDC
NDC 70000-0002-02 Leader Nasal Decongestant 30 mg/1 Details
Leader Nasal Decongestant 30 mg/1
Leader Nasal Decongestant is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Cardinal Health 110, LLC. dba Leader. The primary component is PSEUDOEPHEDRINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Pseudoephedrine is used to relieve nasal congestion caused by colds, allergies, and hay fever. It is also used to temporarily relieve sinus congestion and pressure. Pseudoephedrine will relieve symptoms but will not treat the cause of the symptoms or speed recovery. Pseudoephedrine is in a class of medications called nasal decongestants. It works by causing narrowing of the blood vessels in the nasal passages.
Related Packages: 70000-0002-02Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Pseudoephedrine
Product Information
| NDC | 70000-0002 |
|---|---|
| Product ID | 70000-0002_917a4b9a-62f0-479e-8b1f-6c8b37e5ec5f |
| Associated GPIs | 42101020100305 |
| GCN Sequence Number | 005089 |
| GCN Sequence Number Description | pseudoephedrine HCl TABLET 30 MG ORAL |
| HIC3 | B6V |
| HIC3 Description | DECONGESTANTS, ORAL |
| GCN | 20481 |
| HICL Sequence Number | 002091 |
| HICL Sequence Number Description | PSEUDOEPHEDRINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Leader Nasal Decongestant |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Pseudoephedrine HCl |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 30 |
| Active Ingredient Units | mg/1 |
| Substance Name | PSEUDOEPHEDRINE HYDROCHLORIDE |
| Labeler Name | Cardinal Health 110, LLC. dba Leader |
| Pharmaceutical Class | Adrenergic alpha-Agonists [MoA], alpha-Adrenergic Agonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH FINAL |
| Application Number | part341 |
| Listing Certified Through | 2024-12-31 |
Package
Package Images
NDC 70000-0002-02 (70000000202)
| NDC Package Code | 70000-0002-2 |
|---|---|
| Billing NDC | 70000000202 |
| Package | 8 BLISTER PACK in 1 CARTON (70000-0002-2) / 12 TABLET, FILM COATED in 1 BLISTER PACK |
| Marketing Start Date | 2020-01-16 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.05727 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | NASAL DECONGESTANT 30 MG TAB |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
Standard Product Labeling (SPL)/Prescribing Information SPL 25609b66-047c-46e7-bc95-20eb8e6c9617 Details
Uses
Warnings
Do not use
if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric or emotional conditions, or Parkinson’s disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have
- •
- heart disease
- •
- high blood pressure
- •
- thyroid disease
- •
- diabetes
- •
- trouble urinating due to an enlarged prostate gland
Directions
|
adults and children 12 years and over |
|
|
|
children ages 6 to 11 years |
|
|
|
children under 6 years |
do not use this product in children under 6 years of age |
Other information
Inactive ingredients
Principal Display Panel
INGREDIENTS AND APPEARANCE
| LEADER NASAL DECONGESTANT
pseudoephedrine hcl tablet, film coated |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Labeler - Cardinal Health 110, LLC. dba Leader (063997360) |